Featuring perspectives from Dr Ramez N Eskander, Dr Ursula
Matulonis, Dr Kathleen N Moore, Dr Alexander B Olawaiye and Dr
David M O'Malley, moderated by Dr Moore, including the following
topics:
Introduction (00:00)
Current Role of PARP Inhibitors in the Management of Advanced
Ovarian Cancer (OC) — Prof Eskander (2:40)
Strategies Targeting Folate Receptor Alpha in Advanced OC — Dr
Matulonis (27:41)
Other Approved and Promising Investigational Antibody-Drug
Conjugates for Advanced OC — Dr Moore (52:12)
Other Novel Agents and Strategies for Advanced OC — Dr O'Malley
(1:14:35)
Diagnosis and Management of Adverse Events Associated with
Common Therapies for Advanced OC — Dr Olawaiye (1:39:39)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.